{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-089615","form_type":"8-K","ticker":"CTOR","cik":"0001851484","company_name":"CITIUS ONCOLOGY, INC.","filed_at":"2025-09-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.359476+00:00","generated_at":"2026-05-17T06:08:36.061518+00:00","sec_items":["3.02","5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Citius Oncology doubles share reserve to 30M under 2024 equity plan; issues 360K warrants","bullets":["Board approved amendment to 2024 Omnibus Stock Incentive Plan, increasing authorized shares from 15M to 30M.","Issued warrants to purchase 360K shares of common stock at $2.1875, exercisable March 10, 2026, expiring 2031.","Warrants issued in private placement under Section 4(a)(2) to a financial advisor.","No other changes were made to the 2024 Plan besides the share increase."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-089615","json":"https://secwatch.observer/filing/0001213900-25-089615.json","markdown":"https://secwatch.observer/filing/0001213900-25-089615.md","text":"https://secwatch.observer/filing/0001213900-25-089615.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025089615/0001213900-25-089615-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025089615/ea0257909-8k_citius.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:08:36.061518+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ee65bc284b86331d64966d2d9ee6be704fe22395","claim":"CITIUS ONCOLOGY, INC. issued up to 360,000 shares of common stock of warrant to a financial advisor.","evidence_excerpt":"On September 19, 2025, Citius Oncology, Inc. (the “Company) issued to a financial advisor warrants to purchase up to 360,000 shares of our common stock with an exercise price of $2.1875 per shares, that are exercisable on March 10, 2026, and that expire on March 10, 2031.","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025089615/0001213900-25-089615-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"up to 360,000 shares of common stock"},{"label":"Purchaser","value":"a financial advisor"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}